Venture funds omit diagnostics companies: Few success stories
Scoring a success with diagnostics products is hard - so hard that several venture funds refrain from investing in such projects. Danish Novo Seeds and Sunstone Capital are no exeption.
Raising funds in the life science industry is no easy task - especially not for diagnostics companies in Denmark, where the major investors are reluctant to join in.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
%2520Rune%2520Wiik%2520Kristensen%2520(midten)%2520og%2520Peter%2520Larsen%2520(th.))
